2023 Agenda
2024 Agenda coming soon
Wednesday October 25, 2023
11:30-12:45
Lunch & Discussion
Topic
Time
Welcome Reception
Kimpton Aertson Hotel, Woodlea (17th Floor / Rooftop)
6:00-8:30
Thursday October 26, 2023
Topic
Time
Breakfast
Kimpton Aertson, 8th Floor
7:00am
Kickoff & Keynotes
Mara Aspinall, Eric Dishman
8:00-9:20
Discussion
Rob Metcalf
9:20-9:30
Case Studies: Rare Disease
Successful multi-stakeholder collaborations in genetics and drug discovery
Victoria Gray, Alix Lacoste
10:00-10:30
Panel: Rare Disease Diagnostics & Drug Discovery
What is the state of the market in diagnostics, target identification, and patient identification / recruitment for clinical trials and launch planning to support rare disease drug development and commercialization? What are the biggest challenges and most exciting innovations in this space?
Ross Hoffman, Neha Kumar, Ryan Taft
10:30-11:30
Recap & Afternoon Kickoff
12:45-1:00
Investor Perspectives
Leading investors discuss the most interesting trends for investment and impact in the precision medicine space, both today and on the horizon
Matt Bettonville, Leslie Henshaw, Dave Stevenson
1:00-2:00
Case Studies: Oncology
Successful multi-stakeholder collaboration in oncology infrastructure
Mick Correll
2:15-2:45
Panel: The Changing Paradigm of Cancer Screening & Surveillance
There is significant market activity around cancer screening, multi-cancer early detection, and residual disease testing, signaling the coming of a new paradigm of widespread, recurring testing. What does this change mean for clinical practice, health economics, data integration, consumer interactions with the healthcare system, and ultimately, patient outcomes?
Dawn Cardeiro, Jennifer Dickey, Girish Putcha
2:45-3:45
Discussion & Next Steps
Observations from Day 1
Gillian Hooker
4:00-4:30
Music City at Night
One Fourteen at the Wildhorse Saloon (map)
Transportation from the hotel starting at 5:45pm
6:00-8:30
Friday October 26, 2023
Topic
Time
Breakfast
Kimpton Aertson, 8th Floor
7:30am
Kickoff
8:30-8:40
Case Studies
Successful multi-stakeholder collaboration in genetic testing infrastructure
Kathryn Phillips, Sara Riordan
8:40-9:00
Panel: Precision Medicine Beyond Oncology
What is the state of adult genomic medicine in key specialties such as cardiology, nephrology, neurology as well as preventative/family medicine? How do successful models from oncology inform the evolution of precision medicine in these areas?
Sam Asgarian, Lena Chaihorsky, Lee Washington
9:00-10:00
Observations, Insights & Actions
A high-impact summary of key takeaways from the meeting and recommended actions for the group
Tom Osborne, Nick Seddon
10:30-11:30